CLBT Stock Overview
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cellebrite DI Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22.52 |
| 52 Week High | US$22.63 |
| 52 Week Low | US$7.91 |
| Beta | 1.51 |
| 1 Month Change | 14.20% |
| 3 Month Change | 30.17% |
| 1 Year Change | 157.08% |
| 3 Year Change | 178.02% |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Recent updates
Cellebrite: There Are Potential Risks That Could Damper Growth
Nov 08Is There Now An Opportunity In Cellebrite DI Ltd. (NASDAQ:CLBT)?
Oct 30
There Could Be A Chance Cellebrite DI Ltd.'s (NASDAQ:CLBT) CEO Will Have Their Compensation Increased
Sep 10Cellebrite: Rating Downgrade As Valuation Has Caught Up
Aug 27Cellebrite DI Ltd.'s (NASDAQ:CLBT) 29% Share Price Surge Not Quite Adding Up
Aug 17Why We're Not Concerned About Cellebrite DI Ltd.'s (NASDAQ:CLBT) Share Price
Jun 25Is Cellebrite DI Ltd. (NASDAQ:CLBT) Potentially Undervalued?
May 21Cellebrite: Big Fish In A Small Pond
Apr 29Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce
Mar 14Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17
Feb 18There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price
Jan 28Shareholder Returns
| CLBT | US Software | US Market | |
|---|---|---|---|
| 7D | 13.3% | -2.2% | -2.4% |
| 1Y | 157.1% | 22.4% | 23.4% |
Return vs Industry: CLBT exceeded the US Software industry which returned 21.9% over the past year.
Return vs Market: CLBT exceeded the US Market which returned 23.3% over the past year.
Price Volatility
| CLBT volatility | |
|---|---|
| CLBT Average Weekly Movement | 5.3% |
| Software Industry Average Movement | 7.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CLBT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CLBT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,008 | Yossi Carmil | www.cellebrite.com |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company’s DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations.
Cellebrite DI Ltd. Fundamentals Summary
| CLBT fundamental statistics | |
|---|---|
| Market cap | US$4.91b |
| Earnings (TTM) | -US$316.92m |
| Revenue (TTM) | US$385.17m |
12.8x
P/S Ratio-15.5x
P/E RatioIs CLBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CLBT income statement (TTM) | |
|---|---|
| Revenue | US$385.17m |
| Cost of Revenue | US$59.89m |
| Gross Profit | US$325.28m |
| Other Expenses | US$642.21m |
| Earnings | -US$316.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.45 |
| Gross Margin | 84.45% |
| Net Profit Margin | -82.28% |
| Debt/Equity Ratio | 0% |
How did CLBT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:24 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cellebrite DI Ltd. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tal Liani | BofA Global Research |
| Tomer Zilberman | BofA Global Research |
| Tyler Radke | Citigroup Inc |